| Literature DB >> 28421638 |
Kamyar Kalantar-Zadeh1,2,3,4, Susan T Crowley5, Srinivasan Beddhu6, Joline L T Chen1,2, John T Daugirdas7, David S Goldfarb8, Anna Jin1, Csaba P Kovesdy9, David J Leehey7, Hamid Moradi1,2, Sankar D Navaneethan10, Keith C Norris11, Yoshitsugu Obi1,2, Ann O'Hare12, Tariq Shafi13, Elani Streja1,2,3,4, Mark L Unruh14, Tushar J Vachharajani15, Steven Weisbord16, Connie M Rhee1,2,3.
Abstract
Each year approximately 13,000 Veterans transition to maintenance dialysis, mostly in the traditional form of thrice-weekly hemodialysis from the start. Among >6000 dialysis units nationwide, there are currently approximately 70 Veterans Affairs (VA) dialysis centers. Given this number of VA dialysis centers and their limited capacity, only 10% of all incident dialysis Veterans initiate treatment in a VA center. Evidence suggests that, among Veterans, the receipt of care within the VA system is associated with favorable outcomes, potentially because of the enhanced access to healthcare resources. Data from the United States Renal Data System Special Study Center "Transition-of-Care-in-CKD" suggest that Veterans who receive dialysis in a VA unit exhibit greater survival compared with the non-VA centers. Substantial financial expenditures arise from the high volume of outsourced care and higher dialysis reimbursement paid by the VA than by Medicare to outsourced providers. Given the exceedingly high mortality and abrupt decline in residual kidney function (RKF) in the first dialysis year, it is possible that incremental transition to dialysis through an initial twice-weekly hemodialysis regimen might preserve RKF, prolong vascular access longevity, improve patients' quality of life, and be a more patient-centered approach, more consistent with "personalized" dialysis. Broad implementation of incremental dialysis might also result in more Veterans receiving care within a VA dialysis unit. Controlled trials are needed to examine the safety and efficacy of incremental hemodialysis in Veterans and other populations; the administrative and health care as well as provider structure within the VA system would facilitate the performance of such trials.Entities:
Mesh:
Year: 2017 PMID: 28421638 PMCID: PMC5418081 DOI: 10.1111/sdi.12601
Source DB: PubMed Journal: Semin Dial ISSN: 0894-0959 Impact factor: 3.455